AzTrials
AzTrials

Tobacco AbusePhase 1/2NCT01275391

cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use

A Phase 1/2 study testing Computer Screening, Brief Intervention, Referral toTreatment in people with Tobacco Abuse and Alcohol Abuse, run by Boston Children's Hospital at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

In this project we will conduct a pilot study of a brief intervention to reduce teen tobacco, alcohol and drug use that primary care dental practitioners can provide in their offices. Read more about this study

Who is it for?
Ages 12 to 21 years
Conditions the study is for
Tobacco Abuse, Alcohol Abuse, Drug Abuse
What is being tested?
Computer Screening, Brief Intervention, Referral toTreatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Sep 2011to Sep 2013
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 21 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • 12-21 years of age
  • arriving for routine care to dental office

Who cannot join

  • dentally, medically, or psychologically unstable at the time of the visit
  • cannot read or understand English at a 6th grade level
  • unavailable for 1-month post-visit assessment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Hospital Boston

    Boston, Massachusetts, 02115

Other trials in United States

About this study

In this project we will conduct a pilot study of a brief intervention to reduce teen tobacco, alcohol and drug use that primary care dental practitioners can provide in their offices.

Read the detailed description

The goal of this project is to prepare for a large multi-site comparative effectiveness trial of a behavioral intervention, computer-facilitated Screening, Brief Intervention, and Referral to Treatment (cSBIRT) system that targets tobacco, alcohol, and drug use among adolescent dental patients. This enhanced computerized screening system includes: (1) screening, feedback, and provider talking points for tobacco and non-medical use of prescription drugs, (2) an interactive 2-part Motivational Enhancement Therapy module for adolescents at highest risk to complete from home, and (3) technological extenders (TEs), which are computer-generated messages that the provider sends to adolescents during the months following the clinic visit to reinforce the effect of the intervention over time.

Being tested
Computer Screening, Brief Intervention, Referral toTreatment
Keywords
Tobacco use, Alcohol abuse, Drug abuse, Substance use, Prevention, Brief intervention, Screening, Adolescents
Medical subject headings
Tobacco Use Disorder, Alcoholism, Substance-Related Disorders, Tobacco Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Computer Screening, Brief Intervention, Referral toTreatmentBehavioural

    Also called Brief Advice, SBIRT, Screen and Brief Advice

    A computerized screening for tobacco, alcohol and drug use accompanied by 10-15 pages of health information regarding the risks of tobacco, alcohol and drug use. This is followed by a brief conversation with the primary care provider regarding the health risks of tobacco, alcohol and drug use and a referral to treatment for those at high risk of substance use problems.

Study groups in NCT01275391
Study groupRoleWhat they receive
Treatment as Usual Group 1No interventionParticipants will receive treatment as usual and will complete a baseline and 1-month post-visit assessment
Treatment as Usual Group 2No interventionParticipants will receive treatment as usual and complete only the 1-month post-visit assessment
Intervention Group 1ExperimentalComputer Screening, Brief Intervention, Referral toTreatment. Participants will receive the intervention and complete a baseline and 1-month post-visit assessment
Receives: Behavioral: Computer Screening, Brief Intervention, Referral toTreatment
Intervention Group 2ExperimentalComputer Screening, Brief Intervention, Referral toTreatment Participants will receive the intervention and complete only the 1-month post-visit assessment
Receives: Behavioral: Computer Screening, Brief Intervention, Referral toTreatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent days abstinent of tobacco, alcohol and drugs

    Measured: Past 90 days

Secondary outcomes (1)
  1. Prevalence of tobacco, alcohol and drug use

    Measured: Past 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2011 (estimated)
  2. Study startSep 2011
  3. Primary completionMay 2013 (estimated)
  4. Study completionSep 2013 (estimated)

Why it stopped: This project was not funded.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01275391
Sponsor's protocol ID
RFADEcSBIRT
Status last verified
Oct 2016
First submitted
11 Jan 2011
Last updated
7 Oct 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Holliday R, Hong B, McColl E, Livingstone-Banks J, Preshaw PM. Interventions for tobacco cessation delivered by dental professionals. Cochrane Database Syst Rev. 2021 Feb 19;2(2):CD005084. doi: 10.1002/14651858.CD005084.pub4.

    PubMed 33605440

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Computer Screening, Brief Intervention, Referral toTreatment in people with Tobacco Abuse and Alcohol Abuse, run by Boston Children's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 7 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent days abstinent of tobacco, alcohol and drugs (time frame: Past 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01275391, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in